Advertisement

Topics

Sinovac Biotech (NASDAQ:SVA) & Strongbridge Biopharma PLC (SBBP) Head to Head Analysis

12:08 EDT 11 Aug 2017 | Topix

Sinovac Biotech and Strongbridge Biopharma PLC are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, valuation, profitabiliy, analyst recommendations, dividends, earnings and institutional ownership. Sinovac Biotech has a beta of 0.04, meaning that its stock price is 96% less volatile than the S&P 500.

Original Article: Sinovac Biotech (NASDAQ:SVA) & Strongbridge Biopharma PLC (SBBP) Head to Head Analysis

NEXT ARTICLE

More From BioPortfolio on "Sinovac Biotech (NASDAQ:SVA) & Strongbridge Biopharma PLC (SBBP) Head to Head Analysis"

Quick Search
Advertisement
 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...